)
)
Merck Investor Relations Material
Latest events
Q3 2024
Merck
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Merck KGaA
Access all reports
Segment Data
Access more data
Net sales by
Business area
Life Science
Healthcare
Electronics
Expenses by
Financials
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. The company's Life Science business segment focuses on the development, manufacture, marketing and distribution of pharmaceutical products. It offers drugs for a range of therapeutic indications from central nervous system diseases to cardiovascular and metabolic disorders. In addition to its own pharmaceutical activities, MERCK helps develop medicines for customers. The company also participates in the development of active substances with partners.
Key slides for Merck KGaA
CMD 2024
Merck KGaA
CMD 2024
Merck KGaA
Latest articles
)
Evolution: The Live Casino Juggernaut
With ~49% CAGR since its 2015 IPO, 60%+ EBIT margin, and global dominance in live casino, the story of Evolution is truly one for the books.
22 Nov 2024
)
House of Warhammer: The Inner Workings of Games Workshop
A look under the hood of Games Workshop, a high-margin business in an incredibly niche market, with sky-high stock returns.
15 Nov 2024
)
Crafting a Solid Equity Story: A Strategic Guide for Investor Relations Professionals
Craft a compelling equity story: Align narratives with data to attract ideal investors and build trust with Quartr Pro's powerful IR tools.
13 Nov 2024
Ticker symbol
MRK
Country
🇩🇪 Germany